WO2002064833A1 - Procede de detection de polymorphisme de nucleotide - Google Patents
Procede de detection de polymorphisme de nucleotide Download PDFInfo
- Publication number
- WO2002064833A1 WO2002064833A1 PCT/JP2002/001222 JP0201222W WO02064833A1 WO 2002064833 A1 WO2002064833 A1 WO 2002064833A1 JP 0201222 W JP0201222 W JP 0201222W WO 02064833 A1 WO02064833 A1 WO 02064833A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleotide
- base
- nucleic acid
- target nucleic
- detecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
Definitions
- Base substitution polymorphisms are said to exist at a rate of about one in hundreds to 1000 bases, and it is estimated that there are 3 to 10 million SNPs in the human genome. SNPs are attracting attention as an index for searching for disease-related genes, their susceptibility to disease, and differences in sensitivity (effects, side effects) to drugs. Research is also being conducted on detection methods. I have.
- the hybridization method detects the presence or absence of base substitution by hybridization between a nucleic acid sample and a probe. In this method, it is necessary to find a probe whose hybridization is influenced by a single base difference and hybridization conditions, and it is difficult to construct a detection system having high reproducibility.
- a method using an enzyme there is a method using a DNA polymerase.
- the method further includes (1) a base portion for detecting base substitution described in US Pat. No. 5,137,806.
- a method for detecting base substitution based on the presence or absence of a primer extension reaction using a primer whose 3 'end is annealed (2) Starting from the 3' end described in WO 01/42498
- a method that uses a primer in which the base substitution site to be detected is located at the second nucleotide and detects the base substitution based on the presence or absence of a primer extension reaction.
- a method using an enzyme having an activity of recognizing and cleaving a special structure of a double-strand nucleic acid such as the Invader method described in US Pat. No. Cleavase is known as such an enzyme, and when a base substitution is present (or not present), a probe is designed to form a structure recognized by the enzyme, and the cleavage of the probe is examined. This makes it possible to detect base substitution.
- the method using an enzyme having an activity of recognizing and cleaving a special structure of a double-stranded nucleic acid has a problem in its sensitivity.
- the present inventors can anneal to a target nucleic acid whose base substitution is to be detected, and in an intact state, a DNA extension reaction by a DNA polymerase is not started from its 3 ′ end, and Nucleotides were prepared such that the cleavage by nucleases depends on the base sequence of the annealed type I strand. Further, the present invention was completed by constructing a method capable of detecting base substitution on a target nucleic acid accurately and with high sensitivity using the nucleotide.
- nucleotide In a complex formed from the nucleotide and the target nucleic acid, if a mismatch exists between the specific base and a base on the nucleotide corresponding to the base, the nucleotide is not cleaved by a nuclease. And, when there is no mismatch between the specific base and the base on the nucleotide corresponding to the base, the nucleotide contains a sequence that is cleaved by a nuclease to generate a new 3 ′ end.
- the third end is modified so that extension from the end by DNA polymerase does not occur.
- the nucleotide used in the detection method according to the first or second invention is a nucleotide having a sequence that does not cause a mismatch in a complex formed with the target nucleic acid when there is no base substitution in the target nucleic acid; Any nucleotide having a sequence that does not cause a mismatch in the complex formed with the target nucleic acid when a base substitution is present in the nucleic acid may be used.
- the third invention of the present invention relates to a method for analyzing the genotype of an allele using the method for detecting a base substitution according to the first or second invention of the present invention.
- a sixth invention of the present invention relates to a kit used for detecting a base substitution on a target nucleic acid, characterized in that it contains the nucleotides of the fourth and fifth inventions.
- the kit of the sixth invention includes a kit containing a nuclease and ⁇ or DNA polymerase, a kit further containing a reagent for detecting the presence or absence of DN ⁇ extension, and a reagent for performing a nucleic acid amplification method. Further, those which are contained may be mentioned. BRIEF DESCRIPTION OF THE FIGURES
- FIG. 6 is a view showing the result of detection of a base substitution on a human gene by the method for detecting a base substitution of the present invention.
- FIG. 7 is a view showing the result of detection of base substitution on a human gene by the method for detecting base substitution of the present invention.
- base substitution means that at a specific site on a nucleic acid, a part of the base is replaced by another base.
- the “base substitution” causes a difference in genetic information between living organisms, and this difference in genetic information is called polymorphism or variation.
- base substitution includes base substitution in the above polymorphisms and noriations. Further, base substitution artificially introduced into a nucleic acid is also included in the term “base substitution” in the present specification.
- the number of substituted bases is not particularly limited, and one or more bases may be substituted.
- the present invention is particularly suitable for detecting genomic polymorphisms and variations, particularly for detecting SNPs (base substitution polymorphisms) on genes.
- the nucleotide of the present invention has a base sequence that can anneal to a region on the target nucleic acid including a portion where base substitution is to be detected. In the intact state, it does not function as a primer for DNA extension by DNA polymerase, but can function as a primer only after being cleaved by nuclease.
- the chain length is not particularly limited as long as it has the above properties.
- Both oligonucleotides and polynucleotides can be used in the present invention. Usually, an oligonucleotide of 8 to 50 bases, preferably 10 to 40 bases, particularly preferably 12 to 30 bases is used as the nucleotide of the present invention.
- the nucleotide used in the present invention has the following properties for detecting base substitution at a specific base on a target nucleic acid.
- nucleotide In the complex formed from the nucleotide and the target nucleic acid, there is a mismatch between the specific base and a base corresponding to the base, ie, a base on a nucleotide that forms a hydrogen bond with the base (or Absent) if not nucleotchi
- the nucleotide is not cleaved by a nuclease, and if no mismatch exists (or exists) between the specific base and a base on the nucleotide corresponding to the base, the nucleotide is cleaved by the nuclease Contains a sequence that creates a new 3 'end.
- the 5′-side fragment of the nucleotide cleaved by the nuclease can maintain the state of being annealed to the target nucleic acid. Also, this nucleotide
- the nucleotide of the present invention has a base sequence that can anneal to a region where base substitution of a target nucleic acid is to be detected under the conditions used. That is, it is sufficient that the target nucleic acid has a sequence that is substantially complementary to the target nucleic acid, and has a base sequence that is completely complementary to the target nucleic acid within a range that does not hinder detection of substitution at the target base. You don't have to.
- thermostable ribonuclease H examples include, for example, Bacillus caldotenax, Pyrococcus-Pyrococcus furiosus, Pyrococcus, Pyrococcus horikoshii, Thermococcus litomatis, lit. ), Ribonuclease H derived from Arcaeoglobus fulgidus, Methanococcus jannashi, and the like.
- thermophilic Bacillus bacterium-derived DNA polymerase Bst DNA polymerase, Bea DNA polymerase
- Thermus bacterium-derived DNA polymerase T aq DN A polymerase and the like
- thermophilic archaebacterial-derived skeletal DNA polymerase Pfu DNA polymerase and the like
- nucleotide of the present invention there is a base substitution based on the presence or absence of its cleavage by a nuclease. Determine whether or not the key is valid.
- a single-stranded or double-stranded nucleic acid that is, DNA or RNA can be used.
- RNA a target nucleic acid. It is possible to detect substitutions.
- a sample containing the target nucleic acid can be used for the detection reaction.
- the nucleic acid amplification reaction described above is not particularly limited, and various nucleic acid amplification methods using a primer having a sequence complementary to the type III nucleic acid can be used.
- various nucleic acid amplification methods using a primer having a sequence complementary to the type III nucleic acid can be used.
- polymerase chain reaction PCR; U.S. Pat. Nos. 4,683,195, 4,683,202 and 4,800,159
- SDA strand displacement amplification
- Tokiko 7-114718 self-sustained sequence replication
- IASBA method nucleic acid sequence based amplification, Patent No. 2650159
- TMA method nucleic acid sequence based amplification, Patent No. 2650159
- amplification methods such as Chimeric primer-initiated Amplification of Nucleic acids, WO 00/56877, can be used.
- base substitution on a target nucleic acid can be detected by using the nucleotide of the present invention as a primer when synthesizing DNA complementary to type I DNA chain.
- base substitution can also be used by the PCR method.
- the nucleotide of the present invention may be used in place of one of the primers in the PCR method, and a nuclease corresponding to the nucleotide may be further added to an ordinary reaction solution for PCR.
- base substitution can be detected with high sensitivity by selecting a nuclease that does not inactivate under PCR conditions.
- the cells of higher animals, including humans, are usually diploids with one pair of chromosomes.
- reaction solution 501 for total CPM and the reaction solution 501 for blank were prepared by adding 1 ⁇ l of an enzyme diluent instead of the enzyme solution.
- the sample was applied to a RE SOURS ES column (manufactured by Amersham Pharmacia Biotech) which had been equilibrated with Knoffer A, and chromatographed using an F PLC system (manufactured by Amersham Pharmacia Biotech). As a result, the RNAseHII passed through the RE SOUR SE S column.
- nucleotides of codon 12 on 12R, 12C, and 12S prepared in Example 1- (1) were used as nucleotides that can be specifically distinguished.
- a chimeric oligonucleotide having the indicated base sequence was synthesized.
- SEQ ID NOs: 10, 11, and 12 each have a nucleotide sequence corresponding to an allele whose codon 12 is Cys, Arg, or Ser. All of these are nucleotides in which the hydroxyl group at the 3-position of the ribose moiety of the 3, -terminal nucleotide is aminohexylated. Using these nucleotides and the antisense primer described in Rooster S Column No.
- a method for detecting whether the gene is homozygous or heterozygous was examined.
- a11e1e of the 636th base of human CYP2C19 was selected.
- a DNA fragment of which the 636th base of human CYP2C19 is G or A was converted to a PC Amplified by R reaction and cloned into pT7-B1ue vector. Plasmids from which these DNA fragments had been cleaved were each purified by a conventional method to obtain plasmids 636G and 636A, respectively.
- the amplified DNA of interest was detected only when nucleotide 636 G was used, and the CYP 2 C 19 636 base & 1 16
- FIG. 7D is an electrophoresis pattern showing the results of performing typing by PCR-RFLP method using human genomic DNA as type III.
- Lane 1 shows the PCR amplification product
- Lane 2 shows the PCR amplification product as B type. This is the case when processing with amHI.
- nucleotides 636 G and 636 A were synthesized by binding fluorescent labels RoX (manufactured by ABI) and Fam (manufactured by ABI) to the 5 and 5 ends of the nucleotides, respectively.
- the fluorescently labeled nucleotchi Were mixed in equal amounts.
- the detection method was the same as the above (1).
- nucleotide of the present invention and the method for detecting a base substitution using the nucleotide are useful for detecting a naturally occurring or artificially introduced base substitution.
- the present invention can be used for the detection and identification of base substitutions, such as SNPs, occurring on the genomic DNA of an organism such as polymorphisms and variations, and for the search of disease genes in humans, analysis of drug susceptibility, etc. It is also useful in the fields of genomic drug discovery and genomic medicine. Sequence listing free text
- ribonucleotides- other nucleotides are deoxyribonucleotides and the 3 OH group of the nucleotide at 3 'end is protected with amino hexyl group
- SEQ ID NO: 8 Chimeric oligonucleotide primer precursor to detect the nucleotide substitution on human c-Ki-ras gene
- nucleotides 12 to 15 are ribonucleotides
- nucleotide 17 is inosine— other nucleotides are deoxyribonucleotides and the 3 OH group of the nucleotide at 3 'ena is protected with amino hexyl group
- ribonucleotides- other nucleotides are deoxyribonucleotides and the 3 '-OH group of the nucleotide at 3' end is protected with amino hexyl group "SEQ ID NO: 11: Chimeric oligonucleotide to detect the nucleotide substitution on human c-Ki-ras gene," nucleotides 13 to 15 are
- SEQ ID NO: 13 Nucleotide sequence of AF0621 gene from Archaeoglobus fulgidus.
- polypeptide having a RNaseHII activity from Archaeoglobus fulgidus having a RNaseHII activity from Archaeoglobus fulgidus.
- SEQ ID NO: 16 Nucleotide sequence of ORF in RnaseHII from Archaeoglobus fulgidus.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002232177A AU2002232177B2 (en) | 2001-02-15 | 2002-02-14 | Method of detecting nucleotide polymorphism |
KR1020037010391A KR100809949B1 (ko) | 2001-02-15 | 2002-02-14 | 염기 치환의 검출 방법 |
CA002438574A CA2438574C (en) | 2001-02-15 | 2002-02-14 | Method of detecting nucleotide polymorphism |
EP02712338A EP1367136A4 (en) | 2001-02-15 | 2002-02-14 | METHOD FOR DETECTING NUCLEOTIDE POLYMORPHISM |
JP2002565143A JP3681729B2 (ja) | 2001-02-15 | 2002-02-14 | 塩基置換の検出方法 |
US10/468,128 US7135291B2 (en) | 2001-02-15 | 2002-02-14 | Method of detecting nucleotide polymorphism |
EA200300880A EA005141B1 (ru) | 2001-02-15 | 2002-02-14 | Способ детекции нуклеотидного полиморфизма |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001039268 | 2001-02-15 | ||
JP2001-39268 | 2001-02-15 | ||
JP2001040721 | 2001-02-16 | ||
JP2001-40721 | 2001-02-16 | ||
JP2001101055 | 2001-03-30 | ||
JP2001-101055 | 2001-03-30 | ||
JP2001-177381 | 2001-06-12 | ||
JP2001177381 | 2001-06-12 | ||
JP2001290384 | 2001-09-25 | ||
JP2001-290384 | 2001-09-25 | ||
JP2001338440 | 2001-11-02 | ||
JP2001-338440 | 2001-11-02 | ||
JP2001368929 | 2001-12-03 | ||
JP2001-368929 | 2001-12-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002064833A1 true WO2002064833A1 (fr) | 2002-08-22 |
Family
ID=27567022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/001222 WO2002064833A1 (fr) | 2001-02-15 | 2002-02-14 | Procede de detection de polymorphisme de nucleotide |
Country Status (9)
Country | Link |
---|---|
US (1) | US7135291B2 (ja) |
EP (1) | EP1367136A4 (ja) |
JP (3) | JP3681729B2 (ja) |
KR (1) | KR100809949B1 (ja) |
CN (1) | CN100351393C (ja) |
AU (1) | AU2002232177B2 (ja) |
CA (1) | CA2438574C (ja) |
EA (1) | EA005141B1 (ja) |
WO (1) | WO2002064833A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003102178A1 (fr) * | 2002-05-31 | 2003-12-11 | Takara Bio Inc. | Procede de typage de polymorphismes genetiques |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE557105T1 (de) * | 2005-06-23 | 2012-05-15 | Keygene Nv | Strategien für eine hohe durchsatzidentifikation und erkennung von polymorphismen |
US10227641B2 (en) | 2008-04-30 | 2019-03-12 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
EP2644710B1 (en) | 2008-04-30 | 2016-12-21 | Integrated Dna Technologies, Inc. | Rnase-h-based assays utilizing modified rna monomers |
US8911948B2 (en) | 2008-04-30 | 2014-12-16 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
US9434988B2 (en) | 2008-04-30 | 2016-09-06 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
JPWO2010026933A1 (ja) * | 2008-09-03 | 2012-02-02 | タカラバイオ株式会社 | Rna検出用組成物 |
WO2010046067A1 (en) * | 2008-10-20 | 2010-04-29 | Roche Diagnostics Gmbh | Improved allele-specific amplification |
WO2011060014A1 (en) * | 2009-11-13 | 2011-05-19 | Integrated Dna Technologies, Inc. | Small rna detection assays |
US8614071B2 (en) | 2009-12-11 | 2013-12-24 | Roche Molecular Systems, Inc. | Preferential amplification of mRNA over DNA using chemically modified primers |
US9238832B2 (en) | 2009-12-11 | 2016-01-19 | Roche Molecular Systems, Inc. | Allele-specific amplification of nucleic acids |
CA2881200A1 (en) | 2012-02-14 | 2013-08-22 | Great Basin Scientific | Methods of isothermal amplification using blocked primers |
US10131890B2 (en) | 2013-03-14 | 2018-11-20 | Takara Bio Inc. | Method for using heat-resistant mismatch endonuclease |
AU2013381709A1 (en) * | 2013-03-15 | 2015-10-01 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
WO2015073931A1 (en) | 2013-11-14 | 2015-05-21 | Integrated Dna Technologies, Inc. | Dna polymerase mutants having enhanced template discrimination activity |
US11060149B2 (en) | 2014-06-18 | 2021-07-13 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
US10975415B2 (en) | 2014-09-11 | 2021-04-13 | Takara Bio Inc. | Methods of utilizing thermostable mismatch endonuclease |
US9909169B2 (en) | 2014-12-17 | 2018-03-06 | Roche Molecular Systems, Inc. | Allele-specific amplification of nucleic acids using blocking oligonucleotides for wild type suppression |
CN107614681A (zh) * | 2015-03-20 | 2018-01-19 | 宝生物工程株式会社 | 用于检测靶核酸的高灵敏度方法 |
EP3389481A4 (en) | 2015-12-18 | 2019-05-22 | Clear Gene, Inc. | PROCESSES, COMPOSITIONS, KITS AND DEVICES FOR FAST LANALYSIS OF BIOLOGICAL MARKERS |
CN108148895A (zh) * | 2017-12-29 | 2018-06-12 | 星阵(广州)基因科技有限公司 | 用于检测突变的人akt1基因的引物、试剂盒及方法 |
CN113215163B (zh) * | 2021-05-12 | 2023-05-12 | 苏州海苗生物科技有限公司 | 一种特异性扩增目的基因的分子锁及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992002638A1 (en) * | 1990-08-06 | 1992-02-20 | F. Hoffmann-La Roche Ag | Homogeneous assay system |
EP0705905A2 (de) * | 1994-07-16 | 1996-04-10 | Roche Diagnostics GmbH | Verfahren zum sensitiven Nachweis von Nukleinsäuren |
US5660988A (en) * | 1993-11-17 | 1997-08-26 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
JP2001136965A (ja) * | 1999-11-12 | 2001-05-22 | Takara Shuzo Co Ltd | 核酸配列の増幅方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4521509A (en) | 1982-11-24 | 1985-06-04 | Research Corporation | Method for degrading DNA |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5011769A (en) | 1985-12-05 | 1991-04-30 | Meiogenics U.S. Limited Partnership | Methods for detecting nucleic acid sequences |
US4876187A (en) | 1985-12-05 | 1989-10-24 | Meiogenics, Inc. | Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
JP2650159B2 (ja) | 1988-02-24 | 1997-09-03 | アクゾ・ノベル・エヌ・ベー | 核酸増幅方法 |
CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
US5639611A (en) * | 1988-12-12 | 1997-06-17 | City Of Hope | Allele specific polymerase chain reaction |
US5137806A (en) | 1989-12-11 | 1992-08-11 | Board Of Regents, The University Of Texas System | Methods and compositions for the detection of sequences in selected DNA molecules |
US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
US5846717A (en) | 1996-01-24 | 1998-12-08 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
ES2317113T3 (es) * | 1996-01-24 | 2009-04-16 | Third Wave Tech Inc | Escision invasiva de acidos nucleicos. |
NL1002427C2 (nl) * | 1996-02-23 | 1997-08-26 | Akzo Nobel Nv | Bekledingssamenstelling omvattende een bicyclo- of spiroorthoester functionele verbinding. |
US5808108A (en) * | 1997-01-15 | 1998-09-15 | Chappelow; Cecil C. | Polymeric compositions and composites prepared from spiroorthocarbonates and epoxy monomers |
DE19733619C1 (de) | 1997-08-04 | 2000-02-24 | Markus Schuermann | CASE-PCR, ein hochselektives Verfahren zum Nachweis von Onkogenmutationen und Allelvarianten |
WO2000056877A1 (fr) | 1999-03-19 | 2000-09-28 | Takara Shuzo Co., Ltd. | Procede d'amplification d'une sequence d'acide nucleique |
GB9915200D0 (en) * | 1999-06-29 | 1999-09-01 | Janssen Pharmaceutica Nv | Neurotrophic factor receptor |
ATE332371T1 (de) | 1999-07-02 | 2006-07-15 | Invitrogen Corp | Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese |
GB9918150D0 (en) | 1999-08-03 | 1999-10-06 | Univ Sheffield | Nuclease variant |
US6274353B1 (en) * | 1999-09-22 | 2001-08-14 | Genecopoeia, Inc. | Method and compositions for improved polynucleotide synthesis |
WO2001042498A1 (fr) | 1999-12-10 | 2001-06-14 | Toyo Boseki Kabushiki Kaisha | Procede de detection de polymorphisme nucleotidique |
CA2412721A1 (en) | 2000-06-26 | 2002-01-03 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
US6773885B1 (en) * | 2000-09-29 | 2004-08-10 | Integrated Dna Technologies, Inc. | Compositions and methods for visual ribonuclease detection assays |
WO2002063049A2 (en) * | 2001-02-02 | 2002-08-15 | Genome Therapeutics Corporation | Methods for determining a nucleotide at a specific location within a nucleic acid molecule |
US7163790B2 (en) * | 2001-11-28 | 2007-01-16 | Bio-Rad Laboratories, Inc. | Parallel polymorphism scoring by amplification and error correction |
-
2002
- 2002-02-14 EP EP02712338A patent/EP1367136A4/en not_active Withdrawn
- 2002-02-14 AU AU2002232177A patent/AU2002232177B2/en not_active Ceased
- 2002-02-14 JP JP2002565143A patent/JP3681729B2/ja not_active Expired - Fee Related
- 2002-02-14 EA EA200300880A patent/EA005141B1/ru not_active IP Right Cessation
- 2002-02-14 CA CA002438574A patent/CA2438574C/en not_active Expired - Fee Related
- 2002-02-14 CN CNB028079310A patent/CN100351393C/zh not_active Expired - Fee Related
- 2002-02-14 WO PCT/JP2002/001222 patent/WO2002064833A1/ja active Application Filing
- 2002-02-14 KR KR1020037010391A patent/KR100809949B1/ko not_active IP Right Cessation
- 2002-02-14 US US10/468,128 patent/US7135291B2/en not_active Expired - Fee Related
-
2004
- 2004-07-29 JP JP2004221749A patent/JP2004298200A/ja active Pending
-
2005
- 2005-05-17 JP JP2005144399A patent/JP2005245465A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992002638A1 (en) * | 1990-08-06 | 1992-02-20 | F. Hoffmann-La Roche Ag | Homogeneous assay system |
US5660988A (en) * | 1993-11-17 | 1997-08-26 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
EP0705905A2 (de) * | 1994-07-16 | 1996-04-10 | Roche Diagnostics GmbH | Verfahren zum sensitiven Nachweis von Nukleinsäuren |
JP2001136965A (ja) * | 1999-11-12 | 2001-05-22 | Takara Shuzo Co Ltd | 核酸配列の増幅方法 |
Non-Patent Citations (3)
Title |
---|
KATO IKUNOSHIN ET AL.: "SNPs typing gijutsu no tenkai", BIO VENTURE, vol. 1, no. 1, 1 July 2001 (2001-07-01), pages 45 - 52, XP002952465 * |
KOBAYASHI EIJI ET AL.: "Atarashii single nucleotide polymorphism (SNPs) typing ho", JAPANESE JOURNAL OF SCIENCE AND TECHNOLOGY FOR INDENTIFICATION (SEPARATE VOLUME), vol. 6, November 2001 (2001-11-01), pages 73, XP002952464 * |
See also references of EP1367136A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003102178A1 (fr) * | 2002-05-31 | 2003-12-11 | Takara Bio Inc. | Procede de typage de polymorphismes genetiques |
Also Published As
Publication number | Publication date |
---|---|
EP1367136A1 (en) | 2003-12-03 |
KR20030074797A (ko) | 2003-09-19 |
US20040137451A1 (en) | 2004-07-15 |
AU2002232177B2 (en) | 2006-11-09 |
EA005141B1 (ru) | 2004-12-30 |
JPWO2002064833A1 (ja) | 2004-06-17 |
JP2004298200A (ja) | 2004-10-28 |
CA2438574A1 (en) | 2002-08-22 |
EP1367136A4 (en) | 2005-01-12 |
CA2438574C (en) | 2009-08-11 |
EA200300880A1 (ru) | 2004-02-26 |
JP2005245465A (ja) | 2005-09-15 |
JP3681729B2 (ja) | 2005-08-10 |
CN1524127A (zh) | 2004-08-25 |
KR100809949B1 (ko) | 2008-03-06 |
CN100351393C (zh) | 2007-11-28 |
US7135291B2 (en) | 2006-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005245465A (ja) | 塩基置換の検出方法 | |
EP2396426B1 (en) | Method of amplification of gc-rich dna templates | |
WO2005063977A1 (ja) | 核酸の増幅法およびこれを利用した変異核酸の検出法 | |
KR20110138387A (ko) | Fmr1 및 fmr2 유전자의 5´ 비번역 영역을 규명하기 위한 pcr 방법 | |
KR20080100429A (ko) | Cyp2c19 유전자 증폭용 프라이머 세트, 그것을포함하는 cyp2c19 유전자 증폭용 시약 및 그 용도 | |
AU703951B2 (en) | Detection of mismatches by resolvase cleavage on a solid support | |
JP2019509766A (ja) | 海洋生物dnaポリメラーゼ | |
JP6490990B2 (ja) | Cyp2c19遺伝子増幅用プライマーセット、cyp2c19遺伝子増幅用キット、遺伝子増幅方法、多型解析方法、及び薬効判定方法 | |
JPWO2008066163A1 (ja) | Cyp2c9遺伝子増幅用プライマーセット、それを含むcyp2c9遺伝子増幅用試薬およびその用途 | |
JPWO2003102178A1 (ja) | 遺伝子多型のタイピング方法 | |
KR101119417B1 (ko) | 비만 유전자 증폭용 프라이머 세트, 그것을 포함하는 비만 유전자 증폭용 시약 및 그 용도 | |
JP2008161165A (ja) | 競合オリゴヌクレオチドを用いた遺伝子検出法 | |
JP5367365B2 (ja) | Sult1a1遺伝子増幅用プライマーセット、それを含むsult1a1遺伝子増幅用試薬およびその用途 | |
KR101068605B1 (ko) | Nat2 유전자 증폭용 프라이머 셋트, 그것을 포함하는 nat2 유전자 증폭용 시약 및 그 용도 | |
WO2004001063A2 (en) | Methods and compositions for monitoring primer extension and polymorphism detection reactions | |
WO2006070666A1 (ja) | 遺伝子多型の同時検出方法 | |
US7902335B1 (en) | Heat-stable recA mutant protein and a nucleic acid amplification method using the heat-stable recA mutant protein | |
WO1999042595A1 (en) | Mismatch cleavage enzymes from extreme thermophiles and uses thereof | |
JP2008161164A (ja) | 人工ミスマッチ核酸を含むプライマーを用いた遺伝子検出法 | |
JP4019171B2 (ja) | 誤対合修復系を利用したdnaの解析方法および操作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002712338 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037010391 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002565143 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2438574 Country of ref document: CA Ref document number: 2002232177 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10468128 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200300880 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037010391 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 028079310 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002712338 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |